| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |